ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,114.63
-0.01%
US Tech 100
21,618.00
0.43%
다우존스 지수
44,546.08
0.00%
Bitcoin
96,307.24
0.56%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. NBZ (NBZ) 시세

NBZ

NBZ (NBZ)

EU
1.00
0.00
( 0.00% )
업데이트: 09:00:00
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
1.00
매수가
1.00
매도가
1.16
거래량
0.00
0.00 일간 변동폭 0.00
0.83 52주 범위 1.34
market_cap
997k
전일 종가
1.00
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
0.00
발행 주식
997,000
배당수익률
-
주가수익률
-0.74
주당순이익(EPS)
-1.36
매출
347k
순이익
-1.35M

NBZ 정보

섹터
Finance Services
산업
Finance Services
웹사이트
www.nbzfonds.nl
본부
Amsterdam, North Holland, Nld
설립됨
-
NBZ is listed in the Finance Services sector of the 유로넥스트 (Euronext) with ticker NBZ. The last closing price for NBZ was 1.00 €. Over the last year, NBZ shares have traded in a share price range of 0.83 € to 1.34 €.

NBZ currently has 997,000 shares in issue. The market capitalisation of NBZ is 997,000.00 € . NBZ has a price to earnings ratio (PE ratio) of -0.74.

NBZ 최신 뉴스

추가 뉴스
No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10011100DE
40011100DE
120011100DE
260.044.166666666670.9610.83620.95176486DE
52-0.32-24.24242424241.321.340.831051.02428872DE
156-3.24-76.41509433964.247.350.834484.41604805DE
260-3.75-78.94736842114.757.350.833414.30101194DE

NBZ - Frequently Asked Questions (FAQ)

What is the current NBZ share price?
The current share price of NBZ is 1.00 €
How many NBZ shares are in issue?
NBZ has 997,000 shares in issue
What is the market cap of NBZ?
The market capitalisation of NBZ is EUR 997k
What is the 1 year trading range for NBZ share price?
NBZ has traded in the range of 0.83 € to 1.34 € during the past year
What is the PE ratio of NBZ?
The price to earnings ratio of NBZ is -0.74
What is the cash to sales ratio of NBZ?
The cash to sales ratio of NBZ is 2.87
What is the reporting currency for NBZ?
NBZ reports financial results in USD
What is the latest annual turnover for NBZ?
The latest annual turnover of NBZ is USD 347k
What is the latest annual profit for NBZ?
The latest annual profit of NBZ is USD -1.35M
What is the registered address of NBZ?
The registered address for NBZ is STRAWINSKYLAAN 485, AMSTERDAM, NORTH HOLLAND, 1077XX
What is the NBZ website address?
The website address for NBZ is www.nbzfonds.nl
Which industry sector does NBZ operate in?
NBZ operates in the FINANCE SERVICES sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALCYBCybergun
0.0002 €
(100.00%)
9.8M
CYADCelyad Oncology SA
0.815 €
(94.28%)
694.86k
ALNEVNeovacs
0.1281 €
(20.96%)
547.64k
PARROParrot
4.66 €
(20.10%)
40.04k
MLGALGaleo Concept
2.50 €
(19.05%)
148
BELUBeluga NV
0.438 €
(-70.80%)
1k
ARFDSAdeunis DS
0.048 €
(-52.00%)
5.55k
HDFHydrogene De France
6.45 €
(-17.10%)
47.11k
MLIMLImalliance
0.216 €
(-16.92%)
4.16k
MLLOILocasystem International
11.50 €
(-14.18%)
62
ATOAtos SE
0.0034 €
(17.24%)
3.13B
ALVERVergnet
0.0005 €
(0.00%)
59.34M
ALEUPEuroplasma
0.0128 €
(0.00%)
24.37M
BCPBanco Comercial Portugues SA
0.5396 €
(0.11%)
17.62M
LATLatecoere
0.0105 €
(8.25%)
14.6M

토론

전체 피드 보기
i_like_bb_stock i_like_bb_stock 8 초 전
ADIA news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906
ADIA
i_like_bb_stock i_like_bb_stock 31 초 전
nice
Juntao Juntao 44 초 전
$ADIA
ADIA
i_like_bb_stock i_like_bb_stock 58 초 전
news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906
ADIA
i_like_bb_stock i_like_bb_stock 1 분 전
ADIA news Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906
ADIA
IhidfromtheX IhidfromtheX 2 분 전
Ok...Talk of the FDA slowing down etc...No problem here... https://finance.yahoo.com/news/chimerix-announces-fda-acceptance-priority-120000372.html
AVXL
Sideem Sideem 2 분 전
Good to see the pre-green. Will the green stay?
BB
georgie18 georgie18 2 분 전
AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...
AVGR
georgie18 georgie18 2 분 전
AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...
AVGR
Here Today Here Today 2 분 전
Huge Believer and buyer of shares of more than 9.99% of all Outstanding Shares

https://www.sec.gov/Archives/edgar/data/1829635/000095017025021455/xslSCHEDULE_13G_X01/primar
RNAZ
georgie18 georgie18 2 분 전
AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...
AVGR
Crawfors Crawfors 3 분 전
46.5% margins are pretty dang impressive. Can't be upset about that.

$EDXC
EDXC
georgie18 georgie18 3 분 전
AVGR...Looks like it may delist...🥳shows no L2...says internal halt on OTC markets...
AVGR
TheFinalCD TheFinalCD 3 분 전
https://x.com/NuntioBot/status/1891835713668161922
PRPH
Crawfors Crawfors 3 분 전
• Revenue increased 164% year-over-year, reaching $632K in Q4 2024, demonstrating growing demand for our products.

• Our gross margin improved to 46.5%, indicating enhanced financial efficiency.

$EDXC
EDXC
Crawfors Crawfors 3 분 전
Acknowledging the Challenges
It’s no secret that our financial position has been strained, with limited working capital and a heavy reliance on convertible financing in the past. We’ve experienced dilution, debt pressure, and cash flow constraints, all of which have made it difficult to opera
EDXC
Torez Torez 4 분 전
Lots of comedians in here. Short bus party not a yaht party for you all
SHIBUSD
Crawfors Crawfors 4 분 전
https://www.newmediawire.com/news/endexx-corporation-announces-filing-of-q4-2024-financials-removal-of-yield-sign-and-ceo-update-on-growth-strategy-7079432?fbclid=IwY2xjawIhZiJleHRuA2FlbQIxMAABHbyr1bnNTeqMN7dIxtbLtKWPJT_Z-BarsdskOUFhhbk4Yv8wmDhd56UjXg_aem_MXr--hJ2dCo1HspBvETtkA
EDXC
newmedman newmedman 4 분 전
Bombs are going to fly. If you thought trump was a dumbfuck just wait for what's coming.
RobotDroid RobotDroid 5 분 전
A no name reasearch group spews fiction for the paid pumpers. Wow, not impressive at all. Hopium rules, reality falls!
NWBO
AyaStocks AyaStocks 5 분 전
GM $ADIA players! Watching for a move back up to higher levels today. This is way undervalued here below a dime.
ADIA
Crawfors Crawfors 5 분 전
oh okay cool.
EDXC
Here Today Here Today 6 분 전
Watch Out FDA!!!! There is a new Sheriff in town and all your CROOKED DEALS with those Big Pharma's of the world trying to STOP and Destroy new Treatments and or cures before they can begin is coming to an end in my opinion!!!!
ANVS
fredscott36 fredscott36 6 분 전
25/marty to venable.








...
georgie18 georgie18 6 분 전
SEPN...$13.70...🥳...T3 Halt...

georgie18

Member Level
Re: georgie18 post# 674144

Friday, February 14, 2025 3:31:11 PM

Post#
674545
of 674615
SEPN...$13.03...🥳...Slowly creeping up...

최근 히스토리

EU
NBZ
NBZ
BIT
F33415
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지